The IPO Buzz: Generate Biomedicines Prices IPO at $16 Mid-Point & Stock Falls in NASDAQ Debut
AI-driven Generate Biomedicines (GENB) priced its IPO at $16.00 – the mid-point of its range – and sold 25 million shares – the number in the prospectus – to raise $400 million on Thursday night, Feb. 26, 2026. Generate Biomedicines (GENB) shares slid $1.00 to start trading at $15.00 on NASDAQ shortly before 1 p.m. EST on Friday, Feb. 27, 2026. The biotech's NASDAQ debut ca..
Read more February 27, 2026IPO Calendar
| Company | Symbol proposed | Shares (Millions) | Est. $ Volume | Expected to Trade | SCOOP Rating | Rating Change |
|---|---|---|---|---|---|---|
| Generate Biomedicines | GENB | 25.0 | $ 400.0 mil | 2/27/2026 Priced | S/O | S/O |
| Illumination Acquisition Corp. I | ILLUU | 20.0 | $ 200.0 mil | 2/27/2026 Priced | S/O | S/O |
| FreeCast (Direct Listing) | FCST | 19.8 | $ 0.0 mil | 3/3/2026 Tuesday | S/O | S/O |
Last 100 IPOs - February 27, 2026
| Number of IPOs priced : | 100 |
| Number Up: | 55 |
| Number Down: | 39 |
| Number Unchanged: | 6 |
| Percentage Change From Issue Price: | -3.39% |
| Percentage Change for The Nasdaq Composite | 35.22% |
2026 IPO Scorecard - February 27, 2026
| Number of IPOs priced (Excluding 48 units) : | 31 |
| Number Up: | 17 |
| Number Down: | 10 |
| Number Unchanged: | 4 |
| Total Return From Issue Price: | 4.00% |
| The Nasdaq Composite Index YTD % Change | 35.22% |